Skip to main content
OpenTrials

Clinical trial condition

Purpura

Explore clinical trials studying Purpura. Study availability and eligibility vary by location and protocol.

29 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Purpura trial results

Completed

Eltrombopag Phase III Study In Chinese Chronic ITP Patients

NCT01762761

Conditions
Blood Coagulation Disorders, Blood-Borne Infections, Communicable Diseases, +18 more
Locations
  • Novartis Investigative Site Fuzhou, Fujian, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Zhongshan, Guangdong, China
View all 18 locations
View Trial Details
Completed

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)

NCT00908037

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Orange, California, United States
  • GSK Investigational Site Jacksonville, Florida, United States
  • GSK Investigational Site Orlando, Florida, United States
View all 33 locations
View Trial Details
Completed

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

NCT00359463

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +10 more
Locations
  • GSK Investigational Site Gainesville, Florida, United States
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site Randwick, Sydney, New South Wales, Australia
  • GSK Investigational Site Adelaide, South Australia, Australia
View Trial Details
Completed

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

NCT00370331

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • GSK Investigational Site Duarte, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
View all 115 locations
View Trial Details
Completed

EXTEND (Eltrombopag Extended Dosing Study)

NCT00351468

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Novartis Investigative Site Huntsville, Alabama, United States
  • Novartis Investigative Site Mobile, Alabama, United States
  • Novartis Investigative Site Jonesboro, Arkansas, United States
  • Novartis Investigative Site Duarte, California, United States
View all 110 locations
View Trial Details

Related conditions